Accrued Liabilities and Other Liabilities

3 Months Ended

Mar. 31, 2023

Payables and Accruals [Abstract]

Accrued Liabilities and Other Liabilities

Accrued liabilities and other liabilities consisted of the following (in thousands):

	March 31,		December 31,
	2023		2022
Accrued liabilities:
Accrued clinical expense	$	45,495	$	37,604
Accrued manufacturing expense	5,697		6,605
Accrued development expense	5,234		20,107
Accrued compensation and benefits	27,204		40,208
Accrued commercial expense	4,669		3,941
Accrued royalty expense	503		—
Accrued adjustments to product revenue	1,052		152
Lease liability (current)	7,902		7,844
Other accrued expenses	4,524		4,126
Total accrued liabilities	$	102,280	$	120,587
Other liabilities	$	3,304	$	3,022

Other liabilities as of March 31, 2023 and December 31, 2022 consisted primarily of clinical trial-related liabilities.